# reload+after+2024-01-21 21:29:16.959597
address1§One Edwards Way
city§Irvine
state§CA
zip§92614
country§United States
phone§949 250 2500
fax§949 250 2525
website§https://www.edwards.com
industry§Medical Devices
sector§Healthcare
longBusinessSummary§Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides the PASCAL and Cardioband transcatheter valve repair systems for minimally-invasive therapy. In addition, it offers surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; KONECT RESILIA, a pre-assembled aortic tissue valved conduit for patients who require replacement of the valve, root, and ascending aorta; and HARPOON Beating Heart Mitral Valve Repair System for patients with degenerative mitral regurgitation. Further, the company provides critical care solutions, including advanced hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
fullTimeEmployees§17300
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Bernard J. Zovighian', 'age': 55, 'title': 'CEO & Director', 'yearBorn': 1968, 'fiscalYear': 2022, 'totalPay': 1036347, 'exercisedValue': 0, 'unexercisedValue': 1066176}, {'maxAge': 1, 'name': 'Mr. Scott B. Ullem', 'age': 56, 'title': 'Corporate VP & CFO', 'yearBorn': 1967, 'fiscalYear': 2022, 'totalPay': 1089785, 'exercisedValue': 0, 'unexercisedValue': 8923402}, {'maxAge': 1, 'name': 'Mr. Larry L. Wood', 'age': 57, 'title': 'Corporate VP and Group President of TAVR & Surgical Structural Heart', 'yearBorn': 1966, 'fiscalYear': 2022, 'totalPay': 1100450, 'exercisedValue': 4476145, 'unexercisedValue': 2567177}, {'maxAge': 1, 'name': 'Mr. Jean-Luc  Lemercier', 'age': 66, 'title': 'Corporate Vice President of Japan, Asia Pacific & Greater China', 'yearBorn': 1957, 'fiscalYear': 2022, 'totalPay': 1235738, 'exercisedValue': 3050413, 'unexercisedValue': 4466731}, {'maxAge': 1, 'name': 'Dr. Todd J. Brinton FACC, M.D.', 'title': 'Corporate VP of Advanced Technology & Chief Scientific Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mark  Wilterding', 'title': 'Vice President of Investor Relations', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Arnold A. Pinkston', 'age': 64, 'title': 'Corporate VP & General Counsel', 'yearBorn': 1959, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Dirksen J. Lehman', 'title': 'Corporate Vice President of Public Affairs', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Donald E. Bobo Jr.', 'age': 61, 'title': 'Corporate Vice President of Strategy & Corporate Development', 'yearBorn': 1962, 'fiscalYear': 2022, 'totalPay': 1262596, 'exercisedValue': 11628841, 'unexercisedValue': 31429904}, {'maxAge': 1, 'name': 'Ms. Christine Z. McCauley', 'age': 58, 'title': 'Corporate Vice President of Human Resources', 'yearBorn': 1965, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
auditRisk§4
boardRisk§5
compensationRisk§3
shareHolderRightsRisk§4
overallRisk§2
governanceEpochDate§1704067200
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§2
payoutRatio§0.0
beta§1.049
priceToSalesTrailing12Months§7.5929756
currency§USD
dateShortInterest§1702598400
forwardEps§2.77
pegRatio§3.67
exchange§NYQ
quoteType§EQUITY
shortName§Edwards Lifesciences Corporatio
longName§Edwards Lifesciences Corporation
firstTradeDateEpochUtc§954167400
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§8cdb36f4-8677-373d-bde5-dd7ead8c731e
gmtOffSetMilliseconds§-18000000
targetHighPrice§96.0
targetLowPrice§57.0
targetMeanPrice§78.81
targetMedianPrice§80.0
recommendationMean§2.5
recommendationKey§buy
numberOfAnalystOpinions§26
quickRatio§2.152
earningsGrowth§0.145
grossMargins§0.77989
ebitdaMargins§0.29512
trailingPegRatio§4.456
